Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DNA Loading and Release Using Custom-Tailored Poly(l-lysine) Surfaces.
Shakiba A, Patil SL, Zenasni O, Schmitt ME, Gunaratne PH, Lee TR. Shakiba A, et al. Among authors: patil sl. ACS Appl Mater Interfaces. 2017 Jul 19;9(28):23370-23378. doi: 10.1021/acsami.7b05024. Epub 2017 Jul 10. ACS Appl Mater Interfaces. 2017. PMID: 28636320
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
Pan Y, Robertson G, Pedersen L, Lim E, Hernandez-Herrera A, Rowat AC, Patil SL, Chan CK, Wen Y, Zhang X, Basu-Roy U, Mansukhani A, Chu A, Sipahimalani P, Bowlby R, Brooks D, Thiessen N, Coarfa C, Ma Y, Moore RA, Schein JE, Mungall AJ, Liu J, Pecot CV, Sood AK, Jones SJ, Marra MA, Gunaratne PH. Pan Y, et al. Among authors: patil sl. Oncotarget. 2016 May 3;7(18):25930-48. doi: 10.18632/oncotarget.8412. Oncotarget. 2016. PMID: 27036018 Free PMC article.
Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
Pan Y, Robertson G, Pedersen L, Lim E, Hernandez-Herrera A, Rowat AC, Patil SL, Chan CK, Wen Y, Zhang X, Basu-Roy U, Mansukhani A, Chu A, Sipahimalani P, Bowlby R, Brooks D, Thiessen N, Coarfa C, Ma Y, Moore RA, Schein JE, Mungall AJ, Liu J, Pecot CV, Sood AK, Jones SJ, Marra MA, Gunaratne PH. Pan Y, et al. Among authors: patil sl. Oncotarget. 2017 Mar 7;8(10):17406. doi: 10.18632/oncotarget.15921. Oncotarget. 2017. PMID: 28403581 Free PMC article. No abstract available.
Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies.
Freiwan A, Zoine JT, Crawford JC, Vaidya A, Schattgen SA, Myers JA, Patil SL, Khanlari M, Inaba H, Klco JM, Mullighan CG, Krenciute G, Chockley PJ, Naik S, Langfitt DM, Mamonkin M, Obeng EA, Thomas PG, Gottschalk S, Velasquez MP. Freiwan A, et al. Among authors: patil sl. Blood. 2022 Dec 22;140(25):2684-2696. doi: 10.1182/blood.2021015020. Blood. 2022. PMID: 35914226 Free PMC article.
A Chimeric GM-CSF/IL18 Receptor to Sustain CAR T-cell Function.
Lange S, Sand LGL, Bell M, Patil SL, Langfitt D, Gottschalk S. Lange S, et al. Among authors: patil sl. Cancer Discov. 2021 Jul;11(7):1661-1671. doi: 10.1158/2159-8290.CD-20-0896. Epub 2021 Feb 9. Cancer Discov. 2021. PMID: 33563660 Free PMC article.
29 results